Unusual clinical presentations of gout

Current Opinion in Rheumatology

Volumn 22, Issue 2, 2010, Pages 181-187

  Ning, Tony C ^a   Keenan, Robert T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical; Gout; Presentation; Unusual

Indexed keywords

CYCLOSPORIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; TACROLIMUS; TAMM HORSFALL GLYCOPROTEIN;

COMPUTER ASSISTED TOMOGRAPHY; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GLYCOGEN STORAGE DISEASE; GOUT; HUMAN; HYPERURICEMIA; JOINT PROSTHESIS; LEAD POISONING; NERVE COMPRESSION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN NODULE; TENOSYNOVITIS; UVEITIS;

AGED; DIAGNOSIS, DIFFERENTIAL; GOUT; HUMANS; URIC ACID;

EID: 75749105924     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283361ac0     Document Type: Review

References (67)

1. HelmickCG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008; 58:15-25.
2. Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58:26-35.
3. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med 2005; 143:499-516.
4. Arromdee E, et al. Epidemiology of gout: is the incidence rising? J Rheumatol 2002; 29:2403-2406.
5. Weaver AL. Epidemiology of gout. Cleve Clin J Med 2008; 75 (Suppl 5): S9-S12.
6. Becker MA, Levinson D. Clinical gout and pathogenesis of hyperucimia. 13 ed. In: Koopman WJ, editor. Arthritis and Allied Conditions. 1996.
7. Edwards NL, Gout B, Klippel JH, editors. Clinical and laboratory features, in primer on the rheumatic diseases. New York, London: Springer; 2007.
8. Crawhall JC, Henderson JF, Kelley WN. Diagnosis and treatment of the Lesch-Nyhan syndrome. Pediatr Res 1972; 6:504-513.
9. Puig JG, et al. The spectrum of hypoxanthine-guanine phosphoribosyltrans- ferase (HPRT) deficiency: clinical experience based on 22 patients from 18 Spanish families. Medicine (Baltimore) 2001; 80:102-112.
10. Becker MA, et al. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate. J Lab Clin Med 1982; 99:495-511.
11. Becker MA, et al. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness. Am J Med 1988; 85:383-390.
12. Zhang W, et al. Glycogen storage disease manifested as gout and myopathy: three case reports and literature review. Clin Rheumatol 2008; 27:671-674.
13. Carves C, et al. Gouty tendinitis revealing glycogen storage disease Type Ia in two adolescents. Joint Bone Spine 2003; 70:149-153. (Pubitemid 36528292)
14. Rezende-Lima W, et al. Homozygosity for uromodulin disorders: FJHN and MCKD-type 2. Kidney Int 2004; 66:558-563.
15. Dahan K, et al. Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease? J Am Soc Nephrol 2001; 12:2348-2357.
16. Seegmiller JE, et al. Fructose-induced aberration of metabolism in familial gout identified by 31P magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1990; 87:8326-8330.
17. Halla JT, Ball GV. Saturnine gout: a review of 42 patients. Semin Arthritis Rheum 1982; 11:307-314.
18. Poor G, Mituszova M. Saturnine gout. Baillieres Clin Rheumatol 1989; 3:51-61.
19. Payne M. Lead in drinking water. CMAJ 2008; 179:253-254.
20. Fam AG. Gout in the elderly: clinical presentation and treatment. Drugs Aging 1998; 13:229-243.
21. Thissen CA, Frank J, Lucker GP. Tophi as first clinical sign of gout. Int J Dermatol 2008; 47 (Suppl 1):49-51.
22. West C, Carpenter BJ, Hakala TR. The incidence of gout in renal transplant recipients. Am J Kidney Dis 1987; 10:369-372.
23. Edvardsson VO, et al. Natural history and etiology of hyperuricemia following pediatric renal transplantation. Pediatr Nephrol 1995; 9:57-60.
24. Lin HY, et al. Cyclosporine-induced hyperuricemia and gout. N Engl J Med 1989; 321:287-292.
25. Gerster JC, et al. Gout in liver transplant patients receiving tacrolimus. Ann Rheum Dis 2004; 63:894-895.
26. Burack DA, et al. Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med 1992; 92:141-146.
27. Shibolet O, et al. Reduced incidence of hyperuricemia, gout, and renal failure following liver transplantation in comparison to heart transplantation: a long-term follow-up study. Transplantation 2004; 77:1576-1580.
28. Kostman JR, Rush P, Reginato AJ. Granulomatous tophaceous gout mimicking tuberculous tenosynovitis: report of two cases. Clin Infect Dis 1995; 21:217-219.
29. Chen CK, et al. Carpal tunnel syndrome caused by tophaceous gout: CT and MR imaging features in 20 patients. AJR Am J Roentgenol 2000; 175:655-659.
30. Janssen T, Rayan GM. Gouty tenosynovitis and compression neuropathy of the median nerve. Clin Orthop Relat Res 1987; 216:203-206.
31. Estrada A, Allen NB. Gouty tophus and tarsal tunnel syndrome. J Clin Rheumatol 1999; 5:41.
32. Estrada A, et al. Gouty tophus causing tarsal tunnel syndrome. J Clin Rheumatol 1996; 2:293-298.
33. Jerome JT, Sankaran B, Thirumagal K. Carpal bone involvement in gout. Arch Orthop Trauma Surg 2007; 127:971-974.
34. Ohishi T, et al. Scapholunate dissociation caused by gouty arthritis of the wrist: case report. Scand J Plast Reconstr Surg Hand Surg 2000; 34:189-191.
35. Liu K, et al. Gouty tophus presenting as a soft-tissue mass diagnosed by fine-needle aspiration: a case report. Diagn Cytopathol 1996; 15:246-249.
36. Lee YH, Tan HW, Lee HC. Wrist gouty arthritis presenting as scaphoid erosions with scapholunate ligament disruption. Singapore Med J 2008; 49:e202-e204.
37. Kelly J, et al. Topacheous gout as a rare cause of spinal stenosis in the lumbar region: case report. J Neurosurg Spine 2005; 2:215-217.
38. Chan AT, et al. Thoracic spinal gout mimicking metastasis. Hong Kong Med J 2009; 15:143-145.
39. Barrett K, Miller ML, Wilson JT. Tophaceous gout of the spine mimicking epidural infection: case report and review of the literature. Neurosurgery 2001; 48:1170-1172; discussion 1172-1173.
40. Hou LC, et al. Spinal gout in a renal transplant patient: a case report and literature review. Surg Neurol 2007; 67:65-73; discussion 73.
41. Konatalapalli RM, et al. Gout in the axial skeleton. J Rheumatol 2009; 36:609-613.
42. Wazir NN, et al. Tophaceous gout causing atlanto-axial subluxation mimicking rheumatoid arthritis: a case report. J Orthop Surg (Hong Kong) 2005; 13:203-206.
43. Apibal Y, Jirasuthus S, Puavilai S. Abruption pustular gouty tophi of palm and sole. J Med Assoc Thai 2009; 92:979-982.
44. Dahiya A, Leach J, Levy H. Gouty panniculitis in a healthy male. J Am Acad Dermatol 2007; 57 (2 Suppl):S52-S54.
45. Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005; 142:47-55.
46. Ferry AP, Safir A, Melikian HE. Ocular abnormalities in patients with gout. Ann Ophthalmol 1985; 17:632-635.
47. Lo WR, Broocker G, Grossniklaus HE. Histopathologic examination of conjunctival tophi in gouty arthritis. Am J Ophthalmol 2005; 140:1152-1154.
48. Yulek F, et al. Gout attack with unusual ocular complications. Rheumatol Int 2009; 29:557-559.
49. Gupta S, et al. Pancreatic gout masquerading as pancreatic cancer in a heart transplant candidate. J Heart Lung Transplant 2009; 28:1112-1113.
50. Jaworski RC, Gibson M. Tophaceous aortic valve: a case report. Pathology 1983; 15:197-199.
51. Iacobellis G. A rare and asymptomatic case of mitral valve tophus associated with severe gouty tophaceous arthritis. J Endocrinol Invest 2004; 27:965-966.
52. Scalapino JN, et al. Mitral stenosis associated with valvular tophi. Mayo Clin Proc 1984; 59:509-512.
53. Curtiss EI, Miller TR, Shapiro LS. Pulmonic regurgitation due to valvular tophi. Circulation 1983; 67:699-701.
54. Sharifabad MA, TzengJ,GharibshahiS. Mammary gouty tophus:acase report and review of the literature. Breast J 2006; 12:263-265.
55. Wu H, et al. Intestinal pseudotumorous gouty nodulosis: a colonic tophus without manifestation of gouty arthritis. Hum Pathol 2004; 35:897-899.
56. Carnero S, Teran P, Trillo E. Malignant fibrous histiocytoma arising in a gouty tophus at the second metacarpophalangeal joint. J Plast Reconstr Aesthet Surg 2006; 59:775-778.
57. Schuind FA, et al. Associated giant cell tumor and tophaceous deposits in a finger pulp: a case report. J Hand Surg Am 2003; 28:871-874.
58. Freehill MT, McCarthy EF, Khanuja HS. Total knee arthroplasty failure and gouty arthropathy. J Arthroplasty 2009. [Epub ahead of print]
59. Archibeck MJ, et al. Gout-induced arthropathy after total knee arthroplasty: a report of two cases. Clin Orthop Relat Res 2001; 392:377-382.
60. Healey JH, Dines D, Hershon S. Painful synovitis secondary to gout in the area of a prosthetic hip joint: a case report. J Bone Joint Surg Am 1984; 66:610-611.
61. Ortman BL, Pack LL. Aseptic loosening of a total hip prosthesis secondary to tophaceous gout: a case report. J Bone Joint Surg Am 1987; 69:1096-1099.
62. Guttenplan MD, et al. Laryngeal manifestations of gout. Ann Otol Rhinol Laryngol 1991; 100:899-902.
63. Marion RB, Alperin JE, Maloney WH. Gouty tophus of the true vocal cord. Arch Otolaryngol 1972; 96:161-162.
64. Zhang K, Liu L, Han Y. Pleural effusion of gout. Zhonghua Jie He He Hu Xi Za Zhi 2000; 23:361-362.
65. Nakagawa T, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290:F625-F631. (Pubitemid 43724964)
66. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120:442-447.
67. Choi HK, et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007; 57:109-115.